Concepedia

Safety and Efficacy of SGLT2 Inhibitors for Amyloid Light-Chain Cardiomyopathy

Frederick Lang, Sergio Teruya, Margaret Cuomo, Alfonsina Mirabal Santos, Jai Radhakrishnan, Suzanne Lentzsch, Rajshekhar Chakraborty, Divaya Bhutani, Mathew S. Maurer

Journal of Cardiac Failure · 2024 · 16 citations · 5 references

DOIFull text

Open access

Concepts

References

5

Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy et al. · Journal of Clinical Oncology · 2012 · 1.1K citations · Full text

, , +15

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

, , +15

2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

M. Kittleson, Frederick L. Ruberg, Amrut V. Ambardekar et al. · Journal of the American College of Cardiology · 2023 · 569 citations

, , +15

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

Giovanni Palladini, Ute Hegenbart, Paolo Milani et al. · Blood · 2014 · 503 citations

, , +15

Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction

Javed Butler, Muhammad Usman, Gerasimos Filippatos et al. · JAMA Cardiology · 2023 · 60 citations · Full text

, , +17